نتایج جستجو برای: myocardial infarct size

تعداد نتایج: 710656  

2013
Weike Bao Lucy J Holt Rob D Prince Gavin X Jones Karpagam Aravindhan Mathew Szapacs April M Barbour Larry J Jolivette John J Lepore Robert N Willette Elena DeAngelis Beat M Jucker

BACKGROUND Glucagon-like peptide-1 (GLP-1) and its mimetics reduce infarct size in the setting of acute myocardial ischemia/reperfusion (I/R) injury. However, the short serum half-life of GLP-1 and its mimetics may limit their therapeutic use in acute myocardial ischemia. Domain antibodies to serum albumin (AlbudAbs) have been developed to extend the serum half-life of short lived therapeutic p...

Journal: :Journal of free radicals in biology & medicine 1985
S W Werns M J Shea B R Lucchesi

Myocardial ischemia causes release of chemotactic factors, migration of neutrophils, peroxidation of lipids, and depletion of free radical scavengers. The invading neutrophils may injure the myocardial vasculature and sarcolemma by generating oxygen free radicals. Several agents that affect neutrophils or oxygen radicals were evaluated in a canine model of regional myocardial ischemia and reper...

Journal: :Journal of the American College of Cardiology 2009
Gennaro Sardella Massimo Mancone Chiara Bucciarelli-Ducci Luciano Agati Raffaele Scardala Iacopo Carbone Marco Francone Angelo Di Roma Giulia Benedetti Giulia Conti Francesco Fedele

OBJECTIVES The purpose of this study was to evaluate the impact on myocardial perfusion and infarct size as assessed by contrast-enhanced magnetic resonance imaging (CE-MRI) of a manual thrombectomy device, Export Medtronic (EM) (Medtronic Inc., Minneapolis, Minnesota), as adjunctive therapy in primary percutaneous coronary intervention (PPCI) in a subset of patients with anterior ST-segment el...

Journal: :Circulation 1975
R Roberts

Until recently, the use of nitroglycerin in patients with acute myocardial infarction has been contraindicated primarily because of possible hypotension or tachycardia which, with sublingual or oral preparations, would be difficult to control. The introduction of intravenous nitroglycerin and its use during experimentally induced infarction paved the way for its use in patients with acute myoca...

2005
Kasem Nithipatikom Michael P. Endsley Jeannine M. Moore Marilyn A. Isbell John R. Falck William B. Campbell Garrett J. Gross

Nithipatikom, Kasem, Michael P. Endsley, Jeannine M. Moore, Marilyn A. Isbell, John R. Falck, William B. Campbell, and Garrett J. Gross. Effects of selective inhibition of cytochrome P-450 -hydroxylases and ischemic preconditioning in myocardial protection. Am J Physiol Heart Circ Physiol 290: H500–H505, 2006. First published October 7, 2005; doi:10.1152/ajpheart.00918.2005.—Cytochrome P-450 (C...

Journal: :Circulation research 2015
Robert C Schutt Barry H Trachtenberg John P Cooke Jay H Traverse Timothy D Henry Carl J Pepine James T Willerson Emerson C Perin Stephen G Ellis David X M Zhao Aruni Bhatnagar Brian H Johnstone Dejian Lai Micheline Resende Ray F Ebert Joseph C Wu Shelly L Sayre Aaron Orozco Claudia Zierold Robert D Simari Lem Moyé Christopher R Cogle Doris A Taylor

RATIONALE Despite significant interest in bone marrow mononuclear cell (BMC) therapy for ischemic heart disease, current techniques have resulted in only modest benefits. However, selected patients have shown improvements after autologous BMC therapy, but the contributing factors are unclear. OBJECTIVE The purpose of this study was to identify BMC characteristics associated with a reduction i...

2015
Reuben M. Thomas Sang Yup Lim Beiping Qiang Azriel B. Osherov Nilesh R. Ghugre Hossein Noyan Xiuling Qi Rafael Wolff Michelle Ladouceur-Wodzak Thomas A. Berk Jagdish Butany Mansoor Husain Graham A. Wright Bradley H. Strauss

BACKGROUND Distal coronary embolization (DCE) of thrombotic material occurs frequently during percutaneous interventions for acute myocardial infarction and can alter coronary flow grades. The significance of DCE on infarct size and myocardial function remains unsettled. The aims of this study were to evaluate the effects of DCE sufficient to cause no-reflow on infarct size, cardiac function an...

2011
Ronald Reiter Cory Swingen Luke Moore Timothy D. Henry Jay H. Traverse

Rationale: In rodents, infarct size after ischemia/reperfusion exhibits a circadian dependence on the time of coronary occlusion. It is not known if a similar circadian dependence of infarct size occurs in humans. Objective: To determine if humans exhibit a circadian dependence of infarct size in the setting of ST elevation myocardial infarction (STEMI). Methods and Results: A retrospective ana...

2012
Xiaolin Wu Hong Jiang Lilei Yu Xiaorong Hu Wenwei Liu

Abnormal increase in sympathetic nerve sprouting was responsible for the ventricular arrhythmogenesis after myocardial infarction. This study investigated whether the norepinephrine transporter inhibitor, desipramine, can modulate sympathetic remodeling and ventricular fibrillation threshold (VFT) after myocardial ischemia-reperfusion. Rats were administered desipramine (0.8 mg/kg, i.v.) before...

Journal: :Journal of the American College of Cardiology 2012
Franck Thuny Olivier Lairez François Roubille Nathan Mewton Gilles Rioufol Catherine Sportouch Ingrid Sanchez Cyrille Bergerot Hélène Thibault Thien Tri Cung Gérard Finet Laurent Argaud Didier Revel Geneviève Derumeaux Eric Bonnefoy-Cudraz Meier Elbaz Christophe Piot Michel Ovize Pierre Croisille

OBJECTIVES This study aimed to determine whether post-conditioning at the time of percutaneous coronary intervention could reduce reperfusion-induced myocardial edema in patients with acute ST-segment elevation myocardial infarction (STEMI). BACKGROUND Myocardial edema is a reperfusion injury with potentially severe consequences. Post-conditioning is a cardioprotective therapy that reduces in...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید